Clinical trial · Observational
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
NCT03880721CI-TRIAL-00038784unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Developing a radiomics model to predict the prognosis of patients with hepatocellular carcinoma after microwave ablation to provide advice for their treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Microwave abaltion | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (6)
- label
- Good prognosis
- interventionNames
- Procedure: Microwave abaltion
- label
- Poor prognosis
- interventionNames
- Procedure: Microwave abaltion
- label
- Recurrence
- interventionNames
- Procedure: Microwave abaltion
- label
- Not Recurrence
- interventionNames
- Procedure: Microwave abaltion
- label
- Survival
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with primary hepatocellular carcinoma in the department of interventional ultrasound, PLA general hospital, who accept MWA therapy for HCC Inclusion criteria: 1. Primary hepatocellular 2. No other treatments ware performed before microwave ablation 3. Patient has been clinically diagnosed with HCC definitely, and have a definite operational indication 4. No extrahepatic manifestations and no evidence of vessel invasion and bile duct thrombi Exclusion Criteria: * Exclusion criteria: 1. Non-primary hepatocellular carcinoma or hepatic metastases 2. Accept other treatment before microwave ablation 3. Extrahepatic metastasis, vessel invasion or bile duct thrombi
References
Publications (0)
Data not yet available
No reference posted for this study.